Registration
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) for TRYGG PHARMA, INC.
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA regulatory issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH ENGEL New | Deputy Assistant Secretary for Legislation,Mandatory Health Programs, Dep. of HHSHealth Policy Advisor, U.S. Senate DemocraticPolicy CommitteeLegislative Assistant, Rep. Richard LehmanStaff Assistant/Press Assistant, SenatorBarbara Boxer |
| JOHN MYERS New | Legislative Correspondent, Sen. Arlen SpecterLegislative Aide, Sen. Arlen SpecterLegislative Assistant, Sen. Arlen SpecterSenior Health and Science Policy Advisor, Sen. |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| AKER BIO MARINE (PARENT OF EPAX A/S) | Norway | Norway | — | — |
| EPAX A/S | Norway | Norway | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.